Bioinformatic Analysis of GCN1 as a Novel Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma and Preliminary Exploration of Its Molecular Mechanisms
Figure 2.
Clinical relevance analysis of GCN1 gene expression in liver hepatocellular carcinoma (LIHC). A. Association between GCN1 expression and tumor stage (Pathologic T stage). B. Association between GCN1 expression and AFP (alpha-fetoprotein) levels. C. Association between GCN1 expression and overall survival (OS).